Nisa Investment Advisors’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02K | Hold |
183
| – | – | ﹤0.01% | 2606 |
|
|
2025
Q1 | $1.63K | Buy |
183
+73
| +66% | +$652 | ﹤0.01% | 2520 |
|
|
2024
Q4 | $1.04K | Hold |
110
| – | – | ﹤0.01% | 2673 |
|
|
2024
Q3 | $887 | Buy |
110
+4
| +4% | +$32 | ﹤0.01% | 2607 |
|
|
2024
Q2 | $899 | Sell |
106
-16
| -13% | -$136 | ﹤0.01% | 2544 |
|
|
2024
Q1 | $1.09K | Buy |
122
+82
| +205% | +$735 | ﹤0.01% | 2351 |
|
|
2023
Q4 | $450 | Hold |
40
| – | – | ﹤0.01% | 2431 |
|
|
2023
Q3 | $345 | Sell |
40
-28
| -41% | -$242 | ﹤0.01% | 2593 |
|
|
2023
Q2 | $704 | Hold |
68
| – | – | ﹤0.01% | 2493 |
|
|
2023
Q1 | $1K | Hold |
68
| – | – | ﹤0.01% | 2458 |
|
|
2022
Q4 | $1K | Hold |
68
| – | – | ﹤0.01% | 2510 |
|
|
2022
Q3 | $1K | Buy |
+68
| New | +$1K | ﹤0.01% | 2511 |
|
|
2021
Q4 | – | Sell |
-7,000
| Closed | -$52 | – | 2320 |
|
|
2021
Q3 | $52 | Buy |
+7,000
| New | +$52 | ﹤0.01% | 1924 |
|
|
2021
Q2 | – | Sell |
-3,800
| Closed | -$78 | – | 2383 |
|
|
2021
Q1 | $78 | Hold |
3,800
| – | – | ﹤0.01% | 1860 |
|
|
2020
Q4 | $68K | Buy |
3,800
+113
| +3% | +$2.02K | ﹤0.01% | 1896 |
|
|
2020
Q3 | $55K | Buy |
3,687
+3,247
| +738% | +$48.4K | ﹤0.01% | 1767 |
|
|
2020
Q2 | $9K | Sell |
440
-4,810
| -92% | -$98.4K | ﹤0.01% | 1942 |
|
|
2020
Q1 | $121K | Sell |
5,250
-160
| -3% | -$3.69K | ﹤0.01% | 1324 |
|
|
2019
Q4 | $140K | Sell |
5,410
-3,090
| -36% | -$80K | ﹤0.01% | 1383 |
|
|
2019
Q3 | $166K | Sell |
8,500
-2,699
| -24% | -$52.7K | ﹤0.01% | 1367 |
|
|
2019
Q2 | $183K | Hold |
11,199
| – | – | ﹤0.01% | 1335 |
|
|
2019
Q1 | $254K | Buy |
+11,199
| New | +$254K | ﹤0.01% | 1245 |
|